Loomis, Sayles & Company’s Oak Street Health, Inc. OSH Stock Holding History

Loomis, Sayles & Company’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-99	Closed	-$4K	–	1092
2023 Q1	$4K	Buy	+99	New	+$3.19K	﹤0.01%	919
2021 Q3	–	Sell	-1,944	Closed	-$114K	–	942
2021 Q2	$114K	Sell	1,944 -669	-26%	-$39.8K	﹤0.01%	567
2021 Q1	$142K	Buy	+2,613	New	+$145K	﹤0.01%	529

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Loomis, Sayles & Company's OSH Position: Q2 2023 in Review

Loomis, Sayles & Company sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 99 shares — an estimated $4K sold.

Loomis, Sayles & Company first reported a position in OSH in Q1 2021 and held it in 3 quarters. The position peaked at $142K in Q1 2021. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Loomis, Sayles & Company reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Loomis, Sayles & Company sold 99 Oak Street Health, Inc. shares in Q2 2023, an estimated $4K.
Loomis, Sayles & Company first reported a position in Oak Street Health, Inc. in Q1 2021 and held it in 3 quarters.
Loomis, Sayles & Company's Oak Street Health, Inc. position peaked at $142K in Q1 2021.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.